Trial intelligence / Profile preview

IDP-120 Gel in Acne Vulgaris

NCT03664752Phase 3Completed

Sponsor
Valeant Pharmaceuticals
Start
Dec 2018
Primary completion
May 2020
Modality
Transdermal Patches, Hydrogel Systems, Small Molecules
Countries
2
01

Overview

A Phase 3 trial of IDP-120 vehicle gel in acne vulgaris, sponsored by Valeant Pharmaceuticals. Started Dec 2018; status: completed.

02

Drugs

IDP-120 vehicle gel
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on NCT03664752.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03664752.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call